BioCryst Pharma Stock (NASDAQ:BCRX), Quotes and News Summary

Q: What sector and industry does BioCryst Pharma (BCRX) operate in?

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BioCryst Pharma Stock (NASDAQ: BCRX) stock price, news, charts, stock research, profile.

Open	$5.140
Close	$5.340
Volume / Avg.	3.357M / 3.433M
Day Range	5.060 - 5.350
52 Wk Range	4.030 - 8.960
Market Cap	$1.178B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	69
Short Interest	16.8%
Days to Cover	11.42

Recent News

BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance

BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by Orladeyo revenue growth. With strong patient demand and strategic initiatives, BioCryst projects robust revenue

Vandana Singh

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates

BioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioCryst Pharma (BCRX) stock?

You can purchase shares of BioCryst Pharma (NASDAQ: BCRX) through any online brokerage.

View our list of the best stock brokerages.

Who are BioCryst Pharma's (BCRX) competitors?

Other companies in BioCryst Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).

What is the target price for BioCryst Pharma (BCRX) stock?

The latest price target for BioCryst Pharma (NASDAQ: BCRX) was reported by JMP Securities on Tuesday, May 7, 2024. The analyst firm set a price target for 15.00 expecting BCRX to rise to within 12 months (a possible 162.70% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for BioCryst Pharma (BCRX)?

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $5.71 last updated May 9, 2024 at 7:59 PM EDT.

Does BioCryst Pharma (BCRX) pay a dividend?

There are no upcoming dividends for BioCryst Pharma.

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

BioCryst Pharma’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is BioCryst Pharma (BCRX) going to split?

There is no upcoming split for BioCryst Pharma.

What sector and industry does BioCryst Pharma (BCRX) operate in?

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-